Effect of host‐protein test ( TRAIL / IP ‐10/ CRP ) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial
Academic Emergency Medicine · 2025
DOI: 10.1111/acem.70031 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Academic Emergency Medicine, 2025. Verfasst von Adam J Singer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: Ambulatory Care Facilities, Anti-Bacterial Agents, C-Reactive Protein, Emergency Service, Hospital. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MeMed, Biomedical Advanced Research and Development Authority.
Abstract (Originalsprache)
Objectives
Determining etiology for adults with symptoms of lower respiratory tract infection (LRTI) is challenging. MeMed BV (MMBV), an FDA‐cleared blood test, computationally integrates the levels of three host proteins to differentiate bacterial and viral infections. We evaluated MMBV's impact on safe antibiotic prescribing at emergency department/urgent care centers (ED/UC).
Methods
The JUNO randomized controlled trial (RCT; NCT05762302) was a prespecified pilot phase of the JUPITER RCT. JUNO enrolled adult ED/UC patients with LRTI symptoms and clinician's consideration for antibiotic treatment. Inclusion criteria were fever within 7 days and one of cough, sputum production, dyspnea, or auscultation abnormality. Exclusion criteria were prior antibiotic use or immunosuppression. Patients were randomized to standard care (SC) or SC plus MMBV arms. JUNO's primary objective was to assess antibiotic prescription rate in the SC arm; the secondary objective was to assess JUPITER's study design.
Results
Eleven centers randomized 260 patients, with 214 included (106 SC, 108 MMBV). Median (IQR) age was 40 (28–55.8) years, 57% were female, and 78.5% were enrolled at ED. Common symptoms were cough (93.0%) and chills (70.0%). Overall, antibiotic prescription rates were 30% (95% CI 22% to 40%) and 24% (95% CI 17% to 33%) in the SC arm versus the MMBV (absolute difference of −6% [95% CI −18% to 6%]). More antibiotics were given with bacterial MMBV scores (41% vs. 78%, absolute difference 37%, 95% CI 6% to 61%; n = 40) and less with viral MMBV scores (25% vs. 12%, absolute difference –13%, 95% CI −25% to 0%; n = 144) in the SC versus MMBV arms. There was no increase in ED/UC return visits (8% vs. 3%, difference –6%, 95% CI −12% to 1%) or hospitalizations (3% vs. 0%, difference –3%, 95% CI −7% to 1%) in the SC arm versus the MMBV arm.
Conclusions
JUNO demonstrated that JUPITER's design results in 30% antibiotic prescription rate in the SC arm. JUNO supports that MMBV optimizes antibiotic prescriptions without increasing return ED/UC visits or hospitalizations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
- Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Emergency Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Emergency Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Emergency Medicine, Comprehensive Research Associates, LLC, Houston, Texas, USA.
- Emergency Medicine, Maimonides Medical Center, Brooklyn, New York, USA.
ORCID-Profile: W Frank Peacock, Joby Thoppil, Andrew C Meltzer
Förderung
- MeMed
- Biomedical Advanced Research and Development Authority
Zitieren
APA
Singer, A. J., Hollander, J. E., Kean, E. R., Ring, H., Peacock, W. F., Soto-Ruiz, K. M., Motov, S., Thoppil, J., Hendry, P., Halabi, S., Meltzer, A. C., Headden, G. F., Brosh-Nissimov, T., Zeltser, D., & Cannon, C. M. (2025). Effect of host‐protein test ( TRAIL / IP ‐10/ CRP ) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial. Academic Emergency Medicine. https://doi.org/10.1111/acem.70031
Vancouver
Singer AJ, Hollander JE, Kean ER, Ring H, Peacock WF, Soto-Ruiz KM, et al. Effect of host‐protein test ( TRAIL / IP ‐10/ CRP ) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial. Academic Emergency Medicine. 2025. doi:10.1111/acem.70031
BibTeX
@article{Singer2025,
author = {Singer, Adam J and Hollander, Judd E and Kean, Efrat R and Ring, Hope and Peacock, W Frank and Soto-Ruiz, Karina M and Motov, Sergey and Thoppil, Joby and Hendry, Phyllis and Halabi, Salim and Meltzer, Andrew C and Headden, Gary F and Brosh-Nissimov, Tal and Zeltser, David and Cannon, Chad M},
title = {Effect of host‐protein test ( TRAIL / IP ‐10/ CRP ) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial},
journal = {Academic Emergency Medicine},
year = {2025},
doi = {10.1111/acem.70031}
}
EUVIMED